CannTrust Holdings Inc.

In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.

Cannabis is a hot sector that’s constantly evolving. Right now, how to buy cannabis stocks is a question that’s likely on many investors’ minds.

In this part of our cannabis valuation series, we’ll discuss the multiples of the remaining cannabis stocks and compare them to the peer (MJ) median of 24x.

Canada legalized cannabis in October 2018, so investors expected 2019 to drive marijuana sales. However, the fate of the industry took a sharp turn.

With Biden strongly opposing full-scale legalization, President Trump could turn around things. President Trump might support medical marijuana legalization.

In 2012, Washington was the second state to legalize recreational marijuana. Now, the state plans to revamp its marijuana laws.

It looks like cannabis stocks had a great day. Innovative Industrial Properties (IIPR), Cronos Group (CRON), and Tilray (TLRY) are all surging today.

Cannabis legalization is gaining traction not only in the US but also globally. The third presidential Democratic debate was held on September 12.

In October, Canada completed the second phase of recreational cannabis legalization. This was expected to help drive sales. But that hasn’t been the case.

Cannabis demand is rising, but there seems to be a gap between cannabis demand and supply in Canada. Let’s take a closer look at the imbalance.

Marijuana legalization in the US remains in limbo. Most Democrats have endorsed marijuana legalization. However, Republicans have yet to embrace it fully.

Cannabis is an evolving sector. Recently, Warren Buffett entered the space following Kraft Heinz’s (KHC) newest investment in Flowhub.

Canada’s next wave of cannabis legalization allows edibles, beverages, extracts, and topicals on October 17. The products could hit the stores in December.

HEXO stock has suffered since it reported lower-than-expected third-quarter results in June. The stock has fallen 31.8% since its earnings on June 12.

CannTrust (CTST) was hit with selling pressure this morning as its stock declined almost 5%. However, the overall cannabis sector seems to be positive

Cannabis legalization is a hot topic. With the sudden boom in the cannabis industry, legalization at the national level is vital.

HEXO reported its third-quarter earnings on June 12. The company reported revenues of $13.0 million, which fell short of analysts’ estimate.

Marijuana reform is central to Beto O’Rourke’s 2020 presidential campaign—how could his agenda that affect the cannabis industry?

Canopy Growth’s weak results weighed on the entire cannabis sector. Most of the cannabis stocks were in the red on Thursday.

Cresco Labs (CRLBF) is set to report its Q2 earnings on August 21 after the market closes. The company’s stock fell 5.3% yesterday.

CNN reported that heavyweight champion Mike Tyson said they smoke 10 tons of weed, worth about $40,000, at his California marijuana ranch per month.

Canopy Growth (CGC) rose 1.5% today while Cronos Group (CRON) fell 3.8%. CNBC host Jim Cramer favors both stocks amid several weed industry scandals.

Joe Biden wants to change the criminal justice system because he “believes no one should be in jail because of cannabis use.”

On Monday morning, OrganiGram’s third-quarter earnings came in as a bit of a let-down. Here’s why.

Before the market opened on March 28, CannTrust (CTST) reported its Q4 2018 and full-year earnings.